Literature DB >> 16362805

Chemoprevention of colorectal cancer.

Ramu Raju1, Marcia Cruz-Correa.   

Abstract

Colorectal cancer is a major public health concern in all developed countries. Despite decades of advances in the treatment and prevention of colorectal cancer, it remains the second most common cause of cancer death. However, the optimal method for early detection remains unknown and patient compliance with screening recommendations remains poor. This has led to the development of complementary strategies, such as chemoprevention to reduce morbidity and mortality from colorectal cancer. Chemoprevention is defined as the use of specific pharmacologic or nutrient agents to prevent, reverse, or inhibit the process of carcinogenesis. This review was designed to discuss the most promising agents in colorectal chemoprevention.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16362805     DOI: 10.1007/s10350-005-0170-1

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  8 in total

1.  Serrated adenomas.

Authors:  Wilfredo E De Jesus-Monge; Carmen Gonzalez-Keelan; Marcia Cruz-Correa
Journal:  Curr Gastroenterol Rep       Date:  2009-10

2.  Nonsteroidal anti-inflammatory drugs: effects on mortality after colorectal cancer diagnosis.

Authors:  Jason A Zell; Argyrios Ziogas; Leslie Bernstein; Christina A Clarke; Dennis Deapen; Joan A Largent; Susan L Neuhausen; Daniel O Stram; Giske Ursin; Hoda Anton-Culver
Journal:  Cancer       Date:  2009-12-15       Impact factor: 6.860

3.  Reversibility of aberrant global DNA and estrogen receptor-alpha gene methylation distinguishes colorectal precancer from cancer.

Authors:  Rulong Shen; Lianhui Tao; Yiqing Xu; Shi Chang; James Van Brocklyn; Jian-Xin Gao
Journal:  Int J Clin Exp Pathol       Date:  2008-04-20

Review 4.  Colitis-associated neoplasia: molecular basis and clinical translation.

Authors:  Sebastian Foersch; Markus F Neurath
Journal:  Cell Mol Life Sci       Date:  2014-05-15       Impact factor: 9.261

Review 5.  Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis.

Authors:  Erik S Blomain; Jieru E Lin; Crystal L Kraft; Urszula T Trela; Justin M Rock; Amanda S Aing; Adam E Snook; Scott A Waldman
Journal:  Expert Rev Clin Pharmacol       Date:  2013-08-24       Impact factor: 5.045

6.  A polymorphism in the 3' untranslated region of the gene encoding prostaglandin endoperoxide synthase 2 is not associated with an increase in breast cancer risk: a nested case-control study.

Authors:  David G Cox; Julie Buring; Susan E Hankinson; David J Hunter
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

7.  Dietary patterns and risk of colorectal cancer in Tehran Province: a case-control study.

Authors:  Akram Safari; Zalilah Mohd Shariff; Mirnalini Kandiah; Bahram Rashidkhani; Foroozandeh Fereidooni
Journal:  BMC Public Health       Date:  2013-03-12       Impact factor: 3.295

8.  Outpatient Follow-up and Secondary Prevention for Melanoma Patients.

Authors:  Ryan G Gamble; Daniel Jensen; Andrea L Suarez; Anne H Hanson; Lauren McLaughlin; Jodi Duke; Robert P Dellavalle
Journal:  Cancers (Basel)       Date:  2010-06-07       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.